You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 14, April 11, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Statins and Fracture Risk

Sean Hennessy, PharmD,MSCE; Brian L. Strom, MD,MPH

JAMA. 2001;285:1888-1889.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Loss of bone mass accompanies the aging process and increases risk of fracture, particularly in women. The principal sites of osteoporotic fractures are the forearm, vertebral body, and hip.1 Pharmacological theory2 and in vivo3 and animal4 model observations have suggested that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) may increase bone mineral density, raising the hope that these drugs also may be useful in reducing risk of osteoporotic fractures.

With the publication of the article by van Staa and colleagues5 in this issue of THE JOURNAL, there are now at least 7 studies reported in full publication or abstract form that have measured the association between statin use and fracture risk.5-11 Of these, 6 used observational designs5-10 and 1 reanalyzed data from a randomized trial that was performed to evaluate cardiovascular end points.11 At first glance, these studies appear inconsistent, with 3 positive studies . . . [Full Text of this Article]

Author Affiliations: Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Agency for Healthcare Research and Quality, Rockville, Md; and Center for Education and Research on Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Use of Statins and Risk of Fractures
, , , , and
JAMA. ;285():1850-1855.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.
de Vries et al.
Int J Epidemiol 2006;35:1301-1308.
ABSTRACT | FULL TEXT  

Boning Up (or Down) on Statins
Demer
Arterioscler. Thromb. Vasc. Bio. 2001;21:1565-1566.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.